| Proinflammatory IgG Fc structures in patients with severe COVID-19 S Chakraborty, J Gonzalez, K Edwards, V Mallajosyula, AS Buzzanco, ... Nature immunology 22 (1), 67-73, 2021 | 261 | 2021 |
| Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1 WF Garcia-Beltran, A Hölzemer, G Martrus, AW Chung, Y Pacheco, ... Nature immunology 17 (9), 1067-1074, 2016 | 235 | 2016 |
| Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial DI Bernstein, J Guptill, A Naficy, R Nachbagauer, F Berlanda-Scorza, ... The lancet infectious diseases 20 (1), 80-91, 2020 | 129 | 2020 |
| Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets HL Dugan, CT Stamper, L Li, S Changrob, NW Asby, PJ Halfmann, ... Immunity 54 (6), 1290-1303. e7, 2021 | 111 | 2021 |
| Aging and influenza vaccine-induced immunity HL Dugan, C Henry, PC Wilson Cellular immunology 348, 103998, 2020 | 107 | 2020 |
| SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike JJ Guthmiller, O Stovicek, J Wang, S Changrob, L Li, P Halfmann, ... MBio 12 (1), 10.1128/mbio. 02940-20, 2021 | 101 | 2021 |
| Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans HL Dugan, JJ Guthmiller, P Arevalo, M Huang, YQ Chen, KE Neu, ... Science translational medicine 12 (573), eabd3601, 2020 | 94 | 2020 |
| Broadly neutralizing antibodies target a haemagglutinin anchor epitope JJ Guthmiller, J Han, HA Utset, L Li, LYL Lan, C Henry, CT Stamper, ... Nature 602 (7896), 314-320, 2022 | 80 | 2022 |
| Polyreactive broadly neutralizing B cells are selected to provide defense against pandemic threat influenza viruses JJ Guthmiller, LYL Lan, ML Fernández-Quintero, J Han, HA Utset, DJ Bitar, ... Immunity 53 (6), 1230-1244. e5, 2020 | 69 | 2020 |
| Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID‐19 convalescent plasma clinical trial MLL Madariaga, JJ Guthmiller, S Schrantz, MO Jansen, C Christensen, ... Journal of internal medicine 289 (4), 559-573, 2021 | 55 | 2021 |
| An efficient method to generate monoclonal antibodies from human B cells JJ Guthmiller, HL Dugan, KE Neu, LYL Lan, PC Wilson Human Monoclonal Antibodies: Methods and Protocols, 109-145, 2019 | 49 | 2019 |
| First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes JJ Guthmiller, J Han, L Li, AW Freyn, STH Liu, O Stovicek, CT Stamper, ... Science translational medicine 13 (596), eabg4535, 2021 | 38 | 2021 |
| Evolution of antibody immunity following Omicron BA. 1 breakthrough infection CI Kaku, TN Starr, P Zhou, HL Dugan, P Khalifé, G Song, ER Champney, ... Nature Communications 14 (1), 2751, 2023 | 34 | 2023 |
| Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity PS Briquez, SJ Rouhani, J Yu, AR Pyzer, J Trujillo, HL Dugan, ... Science Advances 8 (40), eabn3777, 2022 | 33 | 2022 |
| Semaphorin 7A modulates cytokine‐induced memory‐like responses by human natural killer cells J Ghofrani, O Lucar, H Dugan, RK Reeves, S Jost European journal of immunology 49 (8), 1153-1166, 2019 | 32 | 2019 |
| Cross-neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spike S Changrob, Y Fu, JJ Guthmiller, PJ Halfmann, L Li, CT Stamper, ... Mbio 12 (6), e02975-21, 2021 | 31 | 2021 |
| Symptomatic SARS-CoV-2 infections display specific IgG Fc structures S Chakraborty, J Gonzalez, K Edwards, V Mallajosyula, AS Buzzanco, ... | 29 | 2020 |
| Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2 CT Stamper, HL Dugan, L Li, NW Asby, PJ Halfmann, JJ Guthmiller, ... Research Square, 2020 | 21 | 2020 |
| Improved integration of single-cell transcriptome and surface protein expression by LinQ-View L Li, HL Dugan, CT Stamper, LYL Lan, NW Asby, M Knight, O Stovicek, ... Cell reports methods 1 (4), 2021 | 12 | 2021 |
| Influence of Glycosylation Inhibition on the Binding of KIR3DL1 to HLA-B* 57: 01 W Salzberger, WF Garcia-Beltran, H Dugan, S Gubbala, C Simoneau, ... PLoS One 10 (12), e0145324, 2015 | 9 | 2015 |
Patrick C WilsonUniversity of ChicagoVerified email at uchicago.edu
